Order Article Reprints

Gonzalez RD, Small GW, Green AJ, Akhtari FS, Havener TM, Quintanilha JCF, Cipriani AB, Reif DM, McLeod HL, Motsinger-Reif AA, et al. RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients. Pharmaceuticals. 2023; 16(5):726. https://doi.org/10.3390/ph16050726

Gonzalez, Ricardo D., George W. Small, Adrian J. Green, Farida S. Akhtari, Tammy M. Havener, Julia C. F. Quintanilha, Amber B. Cipriani, David M. Reif, Howard L. McLeod, Alison A. Motsinger-Reif, and et al. 2023. "RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients" Pharmaceuticals 16, no. 5: 726. https://doi.org/10.3390/ph16050726

Gonzalez, R. D., Small, G. W., Green, A. J., Akhtari, F. S., Havener, T. M., Quintanilha, J. C. F., Cipriani, A. B., Reif, D. M., McLeod, H. L., Motsinger-Reif, A. A., & Wiltshire, T. (2023). RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients. Pharmaceuticals, 16(5), 726. https://doi.org/10.3390/ph16050726